A Dose Confirmation Study of Oral Clofarabine for Adult Patients Previously Treated for Myelodysplastic Syndromes (MDS)

Clinical trial NCT00531232 · COMPLETED

Trial details

NCT number: NCT00531232
Sponsor: Genzyme, a Sanofi Company
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes Secondary Acute Myeloid Leukemia (AML)

Start date: 2007-05-07
Primary completion: 2011-05-12
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.